# PECS I Block for Breast Subpectoral Implant Surgery

> **NCT02849236** · NA · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 56 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Ropivacaine (PECS bloc)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02849236
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-16
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849236, "PECS I Block for Breast Subpectoral Implant Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02849236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*